Bipartisan E&C Leaders Request FDA Briefing on Coronavirus' Impact on Drug, Medical Supplies
March 11, 2020
March 11, 2020
WASHINGTON, March 11 -- Rep. Frank Pallone Jr., D-New Jersey, chairman of the House Energy and Commerce Committee, issued the following news release:
Bipartisan Energy and Commerce Committee leaders wrote to Food and Drug Administration (FDA) Commissioner Stephen M. Hahn, M.D. asking a series of questions and requesting a briefing on the potential impact the novel coronavirus (COVID-19) could have on the supply of safe drugs and other medical products in the United States.
Bipartisan Energy and Commerce Committee leaders wrote to Food and Drug Administration (FDA) Commissioner Stephen M. Hahn, M.D. asking a series of questions and requesting a briefing on the potential impact the novel coronavirus (COVID-19) could have on the supply of safe drugs and other medical products in the United States.